Medical devices firm Quanta Fluid Solutions has announced the appointment of John Milad as chief executive.
Milad’s career spans 20 years, with extensive experience leading and working with international healthcare companies as an executive manager, board member, private equity investor and corporate financier, with a focus on emerging medical technologies.
Milad served as a non-executive director to Quanta for four years following the initial investment in the company he led at NBGI Ventures (NBGI), a venture capital fund investing in medical technology firms.
He currently sits on the i4i selection panel for the NHS National Institute for Health Research, and is a regular speaker and panellist at various global medtech and investment conferences.
Milad said: “I am delighted to lead Quanta as the company enters its next phase of development, when we will soon obtain CE Mark and then commence market introduction for our first product.”
Johan de Ruiter, chairman of Quanta, added: “The Board is delighted to welcome John as Quanta’s new CEO. We have known John for many years as a director of the company and, as a healthcare expert, he has been instrumental in helping us to develop Quanta operationally and strategically.
“I would also like to thank Martin Johnson, our departing CEO and founder, for all the hard work and dedication he has shown to Quanta.”
For the original article, please click